Foresite Capital Management II, LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Foresite Capital Management II, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Foresite Capital Management II, LLC. Foresite Capital Management II, LLC is 10% Owner in AERIE PHARMACEUTICALS INC ($AERI) and 10% Owner in Aimmune Therapeutics, Inc. ($AIMT).
Latest Insider Trading Transactions of Foresite Capital Management II, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2020 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 17.07 | 271,767 | 4,639,063 | 1,229,633 | 1.5 M to 1.2 M (-18.10 %) |
Mar 02 2020 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 17.07 | 425,457 | 7,262,551 | 1,925,020 | 2.4 M to 1.9 M (-18.10 %) |
Mar 02 2020 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 17.07 | 302,776 | 5,168,386 | 1,369,938 | 1.7 M to 1.4 M (-18.10 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.42 | 15,700 | 289,194 | 2,350,477 | 2.3 M to 2.4 M (+0.67 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.42 | 15,700 | 289,194 | 2,350,477 | 2.3 M to 2.4 M (+0.67 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.48 | 90,900 | 1,679,832 | 1,400,900 | 1.3 M to 1.4 M (+6.94 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.48 | 90,900 | 1,679,832 | 1,400,900 | 1.3 M to 1.4 M (+6.94 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.48 | 9,300 | 171,864 | 2,334,777 | 2.3 M to 2.3 M (+0.40 %) |
Sep 06 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 18.48 | 9,300 | 171,864 | 2,334,777 | 2.3 M to 2.3 M (+0.40 %) |
Sep 04 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 21.45 | 15,100 | 323,895 | 2,325,477 | 2.3 M to 2.3 M (+0.65 %) |
Sep 04 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 20.54 | 34,900 | 716,846 | 2,310,377 | 2.3 M to 2.3 M (+1.53 %) |
Sep 04 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 21.36 | 25,000 | 534,000 | 2,275,477 | 2.3 M to 2.3 M (+1.11 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.42 | 38,300 | 896,986 | 2,250,477 | 2.2 M to 2.3 M (+1.73 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.68 | 6,700 | 158,656 | 2,212,177 | 2.2 M to 2.2 M (+0.30 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.42 | 38,300 | 896,986 | 2,250,477 | 2.2 M to 2.3 M (+1.73 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.25 | 1,153 | 26,807 | 2,205,477 | 2.2 M to 2.2 M (+0.05 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.68 | 6,700 | 158,656 | 2,212,177 | 2.2 M to 2.2 M (+0.30 %) |
Aug 23 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.25 | 1,153 | 26,807 | 2,205,477 | 2.2 M to 2.2 M (+0.05 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.21 | 50,000 | 1,160,500 | 2,204,324 | 2.2 M to 2.2 M (+2.32 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.34 | 3,847 | 89,789 | 2,154,324 | 2.2 M to 2.2 M (+0.18 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 24.23 | 100,000 | 2,423,000 | 2,150,477 | 2.1 M to 2.2 M (+4.88 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.21 | 50,000 | 1,160,500 | 2,204,324 | 2.2 M to 2.2 M (+2.32 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.34 | 3,847 | 89,789 | 2,154,324 | 2.2 M to 2.2 M (+0.18 %) |
Aug 20 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 24.23 | 100,000 | 2,423,000 | 2,150,477 | 2.1 M to 2.2 M (+4.88 %) |
Aug 14 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 23.73 | 100,000 | 2,373,000 | 2,050,477 | 2 M to 2.1 M (+5.13 %) |
Aug 14 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 25.52 | 178,903 | 4,565,605 | 1,310,000 | 1.1 M to 1.3 M (+15.82 %) |
Aug 14 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 24.92 | 71,097 | 1,771,737 | 1,131,097 | 1.1 M to 1.1 M (+6.71 %) |
Aug 14 2019 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 24.43 | 189,555 | 4,630,829 | 1,060,000 | 870.4 K to 1.1 M (+21.78 %) |
May 31 2017 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 55.95 | 10,182 | 569,683 | 1,950,477 | 2 M to 2 M (-0.52 %) |
May 31 2017 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 55.95 | 9,818 | 549,317 | 1,672,714 | 1.7 M to 1.7 M (-0.58 %) |
Oct 07 2016 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 40.34 | 25,187 | 1,016,041 | 1,672,697 | 1.7 M to 1.7 M (-1.48 %) |
Oct 07 2016 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 40.34 | 24,813 | 1,000,954 | 1,647,901 | 1.7 M to 1.6 M (-1.48 %) |
Jul 26 2016 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 17.50 | 250,000 | 4,375,000 | 1,697,884 | 1.4 M to 1.7 M (+17.27 %) |
Jun 02 2016 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 15.23 | 120,000 | 1,827,360 | 235,020 | 355 K to 235 K (-33.80 %) |
Jun 02 2016 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 15.23 | 120,000 | 1,827,360 | 3,967,900 | 4.1 M to 4 M (-2.94 %) |
Aug 26 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 19.65 | 25,485 | 500,900 | 355,020 | 329.5 K to 355 K (+7.73 %) |
Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Option Exercise | C | 0.00 | 3,775,400 | 0 | 0 | |
Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 20.50 | 17,035 | 349,199 | 329,535 | 312.5 K to 329.5 K (+5.45 %) |
Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 312,500 | 0 to 312.5 K |
Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | P | 16.00 | 312,500 | 5,000,000 | 4,087,900 | 3.8 M to 4.1 M (+8.28 %) |
Aug 11 2015 | AIMT | Aimmune Therapeuti ... | Foresite Capital Management II ... | 10% Owner | Buy | C | 0.00 | 3,775,400 | 0 | 3,775,400 | 0 to 3.8 M |
Page: 1